- ABMS Certification:
- Internal Medicine, 1987; Gastroenterology, 1989
- Research Interests:
Steatohepatitis, fatty liver, cirrhosis, variceal bleeding, hepatocellular cancer, coagulopathy in liver disease, and viral hepatitis
- Clinical Practice:
- Ascites, Gallbladder Cancer, Liver Cancer, Pancreatic Cancer, Abdominal Paracentesis, Cirrhosis, Liver Biopsy, Upper GI Endoscopy, Gastrointestinal Cancer, Endoscopy, Liver Transplant, Liver Care
Director of Hepatology
Stephen Caldwell, MD, is a hepatologist specializing in a nonalcoholic steatohepatitis (NASH), including its relationship to so-called cryptogenic cirrhosis, ethnic and familial relationships and the role of mitochondrial dysfunction in the disease. He and his colleagues pioneered work on cellular ballooning and the role of small fat droplets in NASH and have also worked extensively with cyanoacrylates in the treatment of gastric variceal bleeding. He is overseeing a number of treatment trials for NASH and a variety of other liver diseases and is closely involved with a network of physicians and scientists working with coagulation disorders in liver disease.
Dr. Caldwell is a native of Statesville, NC. He earned his medical degree from Wake Forest University Medical School. Dr. Caldwell completed his medical residency at a University of Virginia-affiliated program in Roanoke and Salem, VA, where he served as chief resident in his final year. He completed a gastroenterology fellowship program at UVA and a hepatology fellowship at the University of Miami. In 1992, he joined the faculty at UVA, helping to develop the hepatology program.
Now a professor of medicine in the Division of Gastroenterology and Hepatology, Dr. Caldwell is board-certified in internal medicine and gastroenterology.
- 2011-2020 Best Doctors in America® List
- BowmanGray Medical College, WinstonSalem, NC, 1983
- Internal Medicine, Salem VA and Roanoke Hospital
- Gastroenterology, University of Virginia; Hepatology, University of Miami